Within our
bodies, there exists a complex system of billions of beneficial microorganisms
that is integral to our vitality. Whether it be on our skin or in our
intestinal linings, these bacteria perform vital functions that assist in the
maintenance of our health. These bacteria are affected by environmental
factors, age, genetics, etc., and this is concerning due to the rise in obesity
and associated metabolic conditions. These conditions can severely harm ones
health and quality of life, and there is controversy surrounding the treatment.
Since most of these are caused by deleterious bacteria, aggressive antibiotic
treatments have been used to wipe out these pathogens. However, not only do
these eliminate the mutualistic bacteria due to the lack of specificity in
antibiotics, they also can cause immunity to develop in the harmful strain.
This makes further development in antibiotics increasingly difficult, which has
lead to research into an alternative form of treatment known as Fecal
Microbiota Transplantation.
Fecal
Microbiota Transplantation (FMT) is the transplantation of gut flora between
individuals by means of tubes through the anus or mouth to transport the sample to
the desired location. This causes direct implantation of bacteria that will
cause them to outcompete the negative bacteria in order to alleviate patients
of the disease. It was approved by the FDA in the case of Clostridium dificile
(C. dificile) infection due to the ineffectiveness of antibiotics. C. dificile
is a bacteria that infects the colon and causes severe stomach difficulties.
With respect to the efficiency in treatment, FMT proved to be upwards of 90%
effective in remediating the symptoms of C. dificile (Marotz, 2016). The
efficacy of FMT in C. dificile has led to subsequent research into “superdonors”.
These individuals provide a better therapeutic affect and are thought to be
either people who live in the same conditions as the patient or contain a
keystone bacterial species. Although it is not explicitly clear yet, further
research aims at finding what makes these people “superdonors” by testing
samples with high concentrations of different strains of gut flora. Although there are many
positive aspects to this type of treatment, there are several drawbacks.
Besides the obvious social stigma and concerns, many test subjects are very ill
so it is very hard to tell whether the FMT brought about even more illness due to the transfer of bacteria.
Also, there is extreme varying in success, and the difference between a 90+%
and 20% effectiveness can be the difference between the technique being approved
for further treatment or not. Finally, there may be other unintended systemic
affects, however, these may be outweighed by the benefits of the FMT procedure.
-Ethan Subel
LINK TO PAPER:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045147/
Marotz, Clarisse, Zarrinpar, Amir. 2016. “Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation”. Yale Journal of Biology and Medicine, 89: 383-388.
No comments:
Post a Comment